Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Increased THEMIS First Exon Usage in CD4+ T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis.
Expression of switch-associated protein 70 is associated with lymphocyte activation and reduced disability in multiple sclerosis.
Mycophenolate Mofetil for the Treatment of Multiple Sclerosis-associated Uveitis.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
A combined NMR and molecular dynamics simulation study to determine the conformational properties of rat/mouse 35-55 myelin oligodendrocyte glycoprotein epitope implicated in the induction of experimental autoimmune encephalomyelitis.
Increased Sleep Depth in Developing Neural Networks: New Insights from Sleep Restriction in Children.
Transverse myelitis-like presentation of methanol intoxication: A case report and review of the literature.
Use of Disease-Modifying Therapies in Pediatric MS.
AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis.
Role of metabolism in neurodegenerative disorders.
Protocols for Cloning, Expression, and Functional Analysis of Sirtuin2 (SIRT2).
Neurotrophins' Modulation by Olive Polyphenols.
Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment.
Coactivation of Lower Limb Muscles during Gait in Patients with Multiple Sclerosis.
Axonal loss in multiple sclerosis: causes and mechanisms.
Fully automated grey and white matter spinal cord segmentation.
CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?
Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.
Effect of Platelet-Rich Fibrin on Peripheral Nerve Regeneration.
Acute onset blindness: a case of optic neuritis and review of childhood optic neuritis.
Interleukins 17 and 10 in a sample of Egyptian relapsing remitting multiple sclerosis patients.
Comment on the article by Allen et al. 'A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers'
GSK3β Promotes the Differentiation of Oligodendrocyte Precursor Cells via β-Catenin-Mediated Transcriptional Regulation.
The effect of vibrotactile biofeedback of trunk sway on balance control in multiple sclerosis.
Unveiling alterative splice diversity from human oligodendrocyte proteome data.
Pages
« first
‹ previous
…
715
716
717
718
719
720
721
722
723
…
next ›
last »